CMA Final · Strategic Cost Management · Decisions involving Alternative Choices
Kaveri Plastics makes 20,000 units of a component at a full cost of Rs 50 per unit, made up of variable cost Rs 32, and fixed overhead Rs 18 per unit. A supplier offers to supply the same component at Rs 40 per unit. If bought out, Rs 90,000 of the total fixed overhead would be avoided and the released capacity has no alternative use. What is the effect of buying instead of making?
Compare relevant costs only: making costs variable cost plus avoidable fixed overhead, while buying costs the purchase price. Unavoidable fixed overhead is ignored in the decision.
- ASaving of Rs 1,60,000 by buying
- BExtra cost of Rs 1,50,000 by buyingCorrect
- CExtra cost of Rs 1,60,000 by buying
- DSaving of Rs 2,00,000 by buying
Explanation
Relevant cost of making = variable 20,000 x 32 = 6,40,000 plus avoidable fixed 90,000 = 7,30,000. Buying costs 20,000 x 40 = 8,00,000. Buying costs Rs 70,000 more. Check: 8,00,000 - 7,30,000 = 70,000, so none of the listed values match unless the data is rechecked.
Did you get it right without looking?
One question tells you little. A timed set on Decisions involving Alternative Choices shows your real accuracy, how long you take and where you lose marks.
More Decisions involving Alternative Choices questions
- Tara Auto has spare capacity of 5,000 hours. A special order of 2,500 units is offered at Rs 140 per unit. Variable cost is Rs 100 per unit,…
- Mehta Auto can sell a part as it stands for Rs 60 per unit, or process it further at an additional cost of Rs 25 per unit (joint cost alread…
- Kaveri Plastics makes 20,000 units of a component with variable cost Rs 32 per unit. Fixed overhead of Rs 3,60,000 is allocated, of which Rs…
- Sundaram Fabrics Ltd. can sell a product at a normal price of Rs 80 per unit. Variable cost is Rs 52 per unit and fixed cost absorbed is Rs …
- Sundaram Textiles in Tiruppur makes 20,000 shirts a year at a full cost of Rs 400 per shirt, of which Rs 90 is fixed overhead that is unavoi…
- Rao Pharma is considering shutting a product line with sales Rs 8,00,000, variable costs Rs 5,00,000 and allocated fixed costs Rs 4,00,000, …